Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 12, 2007, Pages 1266-1271

  Sancho, Jesús ^a   Servera, Emilio ^a   Díaz, Juan ^a   Marín, Julio ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Assisted cough; Neuromuscular disease; Noninvasive ventilation; Peak cough flow

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BULBAR PARALYSIS; CHEST INFECTION; CONTROLLED STUDY; COUGHING; EXPIRATORY FLOW; FEMALE; FOLLOW UP; HUMAN; INSPIRATORY CAPACITY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; COUGH; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCUS; MULTIVARIATE ANALYSIS; RESPIRATORY INSUFFICIENCY; RESPIRATORY TRACT INFECTIONS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 34250203194     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200612-1841OC     Document Type: Article

References (29)

1. Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs and outcomes. Neurology 2001;56:753-757.
2. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B; EFNS Task Force on Management of Amyotrophic Lateral Sclerosis. Guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921-938.
3. Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory aids. Chest 2002;122:92-98.
4. Sancho J, Servera E, Díaz J, Marín J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004;125:1400-1405.
5. Bach JR. Amyotrophic lateral sclerosis: predictors of life by noninvasive respiratory aids. Arch Phys Med Rehabil 1995;76:828-832.
6. Farrero E, Prats E, Povedano M, Martínez-Matos JA, Manresa F, Escarrabill J. Survival in amyotrophic lateral sclerosis: the impact of systematic assessment and bulbar involvement. Chest 2005;127:1879-1882.
7. Polkey MI, Lyall RA, Green M, et al. Expiratory muscles function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998;158:734-741.
8. Szeinberg A, Tabachnik E, Rashed N, McLaughlin FJ, England S, Bryan CA, Levison H. Cough capacity in patients with muscular dystrophy. Chest 1988;94:1232-1235.
9. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985;58:1776-1782.
10. Bach JR, Saporito LR. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure: a different approach to weaning. Chest 1996;110:1566-1571.
11. Bach JR, Ishikama Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112:1024-1028.
12. Brooks RD, Miller RG, Swash M, Munsatl TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnostic of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
13. Hadjikoutis S, Wiles CM. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand 2001;103:207-213.
14. Norris FH, Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24:721-728.
15. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows: report of Working Party "Standardization of Lung Function Test." Eur Respir J 1993; 6(Suppl 16):5-40.
16. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-702.
17. Mier-Jedrzejowicz M, Brophy C, Green M. Respiratory muscle weakness during respiratory tract infections. Am Rev Respir Dis 1988;138:5-7.
18. Poponick JM, Jacobs I, Supinski G, DiMarco AF. Effect of upper tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med 1997;156:659-664.
19. Servera E, Sancho J, Zafra MJ, Catala A, Vergara P, Marín J. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil 2005;84:851-857.
20. McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129(Suppl 1):455-533.
21. Light RB. Pulmonary pathophysiology of pneumococal pneumonia. Semin Respir Infect 1999;14:218-226.
22. Chaudri MB, Liu C, Hubbard R, Jefferson D, Kinnear WJ. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19:434-438.
23. Bach JR, Rajaraman R, Ballanger F, Tzeng AC, Ishikawa Y, Kulessa R, Bansal T. Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use vs. oxygen therapy on pneumonia and hospitalization rates. Am J Phys Med Rehabil 1998;77:8-19.
24. Sancho J, Servera E, Díaz J, Marín J. Comparison of peak cough flows measured by pneumotachograph and a portable peak flow meter. Am J Phys Med Rehabil 2004;83:608-612.
25. Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000;118:1390-1396.
26. Fontana GA, Pantaleo T, Lavorini F, Mutolo D, Polli G, Pistolesi M. Coughing in laryngectomized patients. Am J Respir Crit Care Med 1999;(5 pt 1):1578-1584.
27. Suleman M, Abaza KT, Gornall C, Kinnear WJM, Willis JS, Majan RP. The effect of a mechanical glottis on peak expiratory flow rate and time to peak flow during a peak expiratory flow manoeuvre: a study in normal subjects and patients with motor neurone disease. Anaesthesia 2004;59:872-875.
28. Mahajan RP, Singh P, Murty GE, Aitkenhead AR. Relationship between expired lung volume, peak flow rate and peak velocity time during a voluntary cough manoeuvre. Br J Anaesth 1994;72:298-301.
29. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5:140-147.